Internal Medicine Doctors in Millstone Township, NJ Accepting Medicare

4 Internal Medicine doctors found. Showing 1 - 4

Dr. Ngozi Erondu, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 63 Baird Rd, Millstone Township, NJ 08535 Phone: 908-816-1233

Pius Chikezie, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 6 Lahaway Creek Ct, Millstone Township, NJ 08510 Phone: 908-770-8025    Fax: 732-321-1150

Dr. Philip M Bonaparte, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5 Rue Court, Millstone Township, NJ 08690 Phone: 609-658-8702

Hany Morris Gendy, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 514 Route 33, Suite 6, Millstone Township, NJ 08535 Phone: 732-851-7007    Fax: 732-786-0012

News Archive

Study: Short-term exposure to major air pollutants may increase risk of MI

Short-term exposure (for up to 7 days) to all major air pollutants, with the exception of ozone, is significantly associated with an increased risk of heart attack, according to a review and meta-analysis of previous studies appearing in the February 15 issue of JAMA.

KHN column: Why $75-a-day matters to caregivers

In his latest Kaiser Health News column, Howard Gleckman writes: "In the ongoing congressional debate over the CLASS Act—the proposed national long-term care insurance program—critics and supporters have been arguing over whether a benefit of $50- or even $75-a-day is worthwhile.

Scientists demonstrate that environmental lithium uptake promotes longevity

Professor Dr. Michael Ristow's team along with Japanese colleagues from universities in Oita and Hiroshima have demonstrated by two independent approaches that even a low concentration of lithium leads to an increased life expectancy in humans as well as in a model organism, the roundworm Caenorhabditis elegans.

Positive preliminary results from Alnylam's ALN-TTR01 Phase I clinical trial for TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today positive preliminary results from its Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).

LecTec settles patent litigation dispute with Endo Pharmaceuticals

LecTec Corporation (OTCBB: LECT) announced today that it has reached a settlement with Endo Pharmaceuticals Inc. on outstanding patent litigation related to LecTec's U.S. Patent Nos. 5,536,263 and 5,741,510. Endo Pharmaceuticals has agreed to make a one–time, $23 million payment for the exclusive license to these two patents for use in the field of prescription pain medicines and treatment.

Read more Medical News

› Verified 3 days ago